127 related articles for article (PubMed ID: 6689183)
21. Effects of molsidomine on exercise tolerance in patients with coronary heart disease.
Messin R; Demaret B; Denolin H
Int J Cardiol; 1983 May; 3(2):137-44. PubMed ID: 6688064
[TBL] [Abstract][Full Text] [Related]
22. Acute and chronic effect of molsidomine extended release on exercise capacity in patients with stable angina, a double-blind cross-over clinical trial versus placebo.
Messin R; Boxho G; De Smedt J; Buntinx IM
J Cardiovasc Pharmacol; 1995 Apr; 25(4):558-63. PubMed ID: 7596123
[TBL] [Abstract][Full Text] [Related]
23. Haemodynamic effects of molsidomine in patients with severe chronic coronary disease.
Crexells C; Lidón RM; Augé JM; Bosch X; Pina C; Garcia J; Oriol A
Eur Heart J; 1985 Dec; 6(12):1032-9. PubMed ID: 3841658
[TBL] [Abstract][Full Text] [Related]
24. [Molsidomine in the long-term treatment of angina pectoris].
Blasini R; Brügmann U; Mannes A; Rudolph W
Herz; 1982 Oct; 7(5):307-16. PubMed ID: 6818116
[No Abstract] [Full Text] [Related]
25. Molsidomine, an effective long-acting anti-anginal drug.
Balakumaran K; Hugenholtz PG; Tijssen JG; Chadha DR
Eur Heart J; 1983 Sep; 4(9):655-61. PubMed ID: 6416844
[TBL] [Abstract][Full Text] [Related]
26. Hemodynamic effects of molsidomine, isosorbide dinitrate, and nifedipine at rest and during exercise.
Schartl M; Dougherty C; Rutsch W; Schmutzler H
Am Heart J; 1985 Mar; 109(3 Pt 2):649-53. PubMed ID: 3838401
[TBL] [Abstract][Full Text] [Related]
27. Penbutolol and molsidomine synergism in angina pectoris. A double blind ergometric trial.
Balestrini AE; Menzio AC; Cabral R; Feldman R; Mercogliano C; Flichtentrei D; Albera HP; Vazquez A
Eur J Clin Pharmacol; 1984; 27(1):1-5. PubMed ID: 6386486
[TBL] [Abstract][Full Text] [Related]
28. Ambulatory monitoring and exercise testing in the evaluation of a new long-acting calcium ion antagonist KB-944 (Fostedil) for the treatment of exertional angina pectoris.
Khurmi NS; Bowles MJ; O'Hara MJ; Lahiri A; Raftery EB
Int J Cardiol; 1985 Nov; 9(3):289-302. PubMed ID: 3902675
[TBL] [Abstract][Full Text] [Related]
29. [Molsidomine in ergometric tests (author's transl)].
Röhl D; Lehmann KH
Dtsch Med Wochenschr; 1980 Aug; 105(35):1216-9. PubMed ID: 6893580
[TBL] [Abstract][Full Text] [Related]
30. [Synergic action of molsidomine and atenolol in patients with exertion angina. Cycloergometric study].
Gimeno JV; Olagüe J; Bueno FJ; Tellols R; Martín G; Ferrer J
Med Clin (Barc); 1984 Nov; 83(15):624-8. PubMed ID: 6549203
[No Abstract] [Full Text] [Related]
31. The antianginal effect of molsidomine in prolonged oral therapy. A double blind, crossover, randomized study.
Baudry C
Acta Cardiol; 1982; 37(1):23-30. PubMed ID: 7044013
[TBL] [Abstract][Full Text] [Related]
32. Molsidomine--an effective antianginal drug. Results of an acute randomized stress-testing study.
Mindlin de Aptecar FR; Vazquez A; Aptecar M
Cardiology; 1985; 72(4):185-92. PubMed ID: 3902224
[TBL] [Abstract][Full Text] [Related]
33. Propranolol in angina pectoris: duration of improved exercise tolerance and circulatory effects after acute oral administration.
Thadani U; Parker JO
Am J Cardiol; 1979 Jul; 44(1):118-25. PubMed ID: 377932
[TBL] [Abstract][Full Text] [Related]
34. Effects of L-carnitine on exercise tolerance in patients with stable angina pectoris.
Kamikawa T; Suzuki Y; Kobayashi A; Hayashi H; Masumura Y; Nishihara K; Abe M; Yamazaki N
Jpn Heart J; 1984 Jul; 25(4):587-97. PubMed ID: 6502941
[TBL] [Abstract][Full Text] [Related]
35. [Pharmacological basis of therapy with molsidomine].
Bassenge E
Herz; 1982 Oct; 7(5):296-306. PubMed ID: 6897544
[TBL] [Abstract][Full Text] [Related]
36. Hemodynamic effects of molsidomine.
Rakovec P
J Cardiovasc Pharmacol; 1980; 2(6):893-4. PubMed ID: 6160337
[No Abstract] [Full Text] [Related]
37. Comparison of the effects of two doses of bisoprolol on exercise tolerance in exercise-induced stable angina pectoris.
de Muinck E; Wagner G; vd Ven LL; Lie KI
Eur Heart J; 1987 Dec; 8 Suppl M():31-5. PubMed ID: 2897300
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the chronic antianginal effect of molsidomine.
Dalla-Volta S; Scorzelli L; Razzolini R
Am Heart J; 1985 Mar; 109(3 Pt 2):682-4. PubMed ID: 3883736
[TBL] [Abstract][Full Text] [Related]
39. Exercise tolerance in coronary patients: randomized trial of two-week treatment with molsidomine versus placebo.
Messin R
Am Heart J; 1985 Mar; 109(3 Pt 2):667-9. PubMed ID: 3883732
[TBL] [Abstract][Full Text] [Related]
40. [Comparison of the effects of molsidomine retard and isosorbide dinitrate retard in patients with stable angina pectoris using an ergometry test].
Rotrekl P; Vlasínová J; Manousek J; Semrád B; Rysavý F; Lupínek Z; Meluzín J; Vlasicová I; Pirochtová I; Bocek O
Vnitr Lek; 1993 Sep; 39(9):856-64. PubMed ID: 8212639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
